【H.W. C】評論
*thienopyridines : inh P2Y12 receptor of ADP -antiplatelet-Ticlopidine: the first drug of P2Y12 receptor antagonist, disadvantage in hematological disorder-Clopidogrel: =Plavix®, need CYP2C19 actived, irreversibly inh P2Y12-Prasugrel: prodrug, actived by intestines esterase, irreversibly-Ticagrelor & Cangrelor : no need actived and metabolite rapidly, reversibly.